Post-approval studies (Phase 4)Study completedNCT03020199
What this trial is testing
Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis
Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 196